Oct 23, 2026
AstraZeneca has begun selling a Chinese-developed lung cancer drug in the U.S. that some American patients had been flying to China to buy.
Japan debt watcher sees resilient PH economy
Oct 24, 2026
[Vantage Point] High barriers, high stakes: The SEC’s liquidity gambit
When the Ifugao rice terraces rest
Lung cancer drug some Americans fly to China to buy is now on sale in US